What Alex Telford thinks about Europe
Writer on biotechnology and the economics of drug development, with a background working in and around the pharmaceutical industry. He writes long, sourced essays at atelfo.github.io on why drugs are hard to discover, what regulation does to that, and where the industry is going.
Alex Telford did not write this page.
We collected these quotes from things they published elsewhere, and every quote links to where it was said. They have no account here and have not endorsed this site. Quotes are word for word; the short line under each one is our own restatement, not their wording. Their own site. Is this you? Claim it or ask us to remove it. Or tell us what is wrong here.
Filter Europe · Newest first
Only Alex Telford on Europe. See everyone on Europe
1 dated position, 2024, in their own words. Our reading of what Alex Telford has said — not written or endorsed by them.
-
Our readingChina now starts about a quarter of the world's new clinical trials, more than Europe does.
Their wordsChinese companies are now responsible for about a quarter of new trial starts — more than Europe.
↗Will all our drugs come from China?atelfo.github.io 2nd of 2 in this piece